Literature DB >> 9749801

Region-specific expression of thyrotrophin-releasing hormone-degrading ectoenzyme in the rat central nervous system and pituitary gland.

H Heuer1, J Ehrchen, K Bauer, M K Schäfer.   

Abstract

Thyrotrophin-releasing hormone (TRH), a hypothalamic neuropeptide hormone and a putative neuromodulator/ neurotransmitter in the central nervous system is inactivated by the TRH-degrading ectoenzyme (TRH-DE), a TRH-specific metallopeptidase localized on the surface of neuronal brain cells in culture and on lactotrophic cells of the pituitary. After succeeding in cloning the cDNA of TRH-DE we now report on the cellular distribution pattern of this enzyme in rat brain, spinal cord and pituitary gland using in situ hybridization histochemistry. In the pituitary, TRH-DE mRNA was found both in the anterior and the neural lobe but not in the intermediate lobe. After treatment with triiodothyronine (T3) a dramatic increase in the mRNA levels of the TRH-DE and a decrease in the intensity of the TRH receptor could be observed in the anterior lobe of the pituitary. In brain, TRH-DE transcripts were predominantly found in neo- and allocortical regions with strongest signals in the olfactory bulb, the piriform cortex, the cerebral cortex, the granular layer of the cerebellar cortex and the pyramidal cells of the Ammon's horn. In the diencephalon, the highest TRH-DE mRNA levels were observed in the medial habenulae followed by several hypothalamic subregions. In the mesencephalon and brainstem, moderate signals were present in the superior colliculi, substantia nigra, dorsal raphe and in the periolivar region. In the spinal cord, TRH-DE mRNA positive neurons were present in all layers. The very distinct distribution of TRH-DE in the brain and the hormonal regulation of the adenohypophyseal enzyme support the concept that this peptidase serves very specialized functions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9749801     DOI: 10.1046/j.1460-9568.1998.00158.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  6 in total

1.  The ups and downs of thyrotropin-releasing hormone.

Authors:  Kristen R Vella; Anthony N Hollenberg
Journal:  Endocrinology       Date:  2009-05       Impact factor: 4.736

2.  Regulation of adenohypophyseal pyroglutamyl aminopeptidase II activity by thyrotropin-releasing hormone and phorbol esters.

Authors:  M A Vargas; M Cisneros; P Joseph-Bravo; J L Charli
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

3.  Thyroxine-induced expression of pyroglutamyl peptidase II and inhibition of TSH release precedes suppression of TRH mRNA and requires type 2 deiodinase.

Authors:  Alessandro Marsili; Edith Sanchez; Praful Singru; John W Harney; Ann Marie Zavacki; Ronald M Lechan; P R Larsen
Journal:  J Endocrinol       Date:  2011-07-25       Impact factor: 4.286

4.  Tanycyte pyroglutamyl peptidase II contributes to regulation of the hypothalamic-pituitary-thyroid axis through glial-axonal associations in the median eminence.

Authors:  Edith Sánchez; Miguel Angel Vargas; Praful S Singru; Isel Pascual; Fidelia Romero; Csaba Fekete; Jean-Louis Charli; Ronald M Lechan
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

Review 5.  The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?

Authors:  Jean-Louis Charli; Adair Rodríguez-Rodríguez; Karina Hernández-Ortega; Antonieta Cote-Vélez; Rosa María Uribe; Lorraine Jaimes-Hoy; Patricia Joseph-Bravo
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

6.  Analysis of the thyrotropin-releasing hormone-degrading ectoenzyme by site-directed mutagenesis of cysteine residues. Cys68 is involved in disulfide-linked dimerization.

Authors:  T Papadopoulos; H Heuer; K Bauer
Journal:  Eur J Biochem       Date:  2000-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.